Eli Lilly & Co. (LLY)

115.20 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (4/30/19)
- M&A (3/31/19 *Est)

Latest Headlines

Pfizer (PFE). Eli Lilly & Co. (NYSE:LLY) Report Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis April 18, 2019 5:06 PM - StreetInsider Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis April 18, 2019 5:05 PM - BizWire Merck (MRK), Lilly (LLY), Pfizer (PFE) Weakness Continues as Biotech Shares Get Hit Again April 18, 2019 10:23 AM - StreetInsider Form 4 LILLY ELI & CO For: Apr 15 Filed by: Walker Karen April 17, 2019 3:50 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 15 Filed by: TAI JACKSON P April 17, 2019 3:46 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 15 Filed by: MARRAM ELLEN R April 17, 2019 3:42 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 15 Filed by: LUCIANO JUAN R April 17, 2019 3:36 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 15 Filed by: Alvarez Ralph April 17, 2019 2:58 PM - SEC Filing Merck (MRK), Pfizer (PFE) Lilly (LLY) Shares Decline Amid Biotech Weakness April 17, 2019 10:26 AM - StreetInsider Form 4 LILLY ELI & CO For: Apr 12 Filed by: Zulueta Alfonso G April 16, 2019 2:48 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 12 Filed by: Barnes Melissa S April 16, 2019 2:37 PM - SEC Filing Eli Lilly & Co. (LLY) option implied volatility as shares trade near record high April 16, 2019 10:17 AM - StreetInsider Form 4 Elanco Animal Health For: Apr 11 Filed by: Scots-Knight Denise April 12, 2019 5:51 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: McDonald Kirk P April 12, 2019 5:47 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: Kurzius Lawrence Erik April 12, 2019 5:44 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: Kochevar Deborah Turner April 12, 2019 5:40 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: HOOVER R DAVID April 12, 2019 5:36 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: Harrington Michael J April 12, 2019 5:32 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: BILBREY JOHN P April 12, 2019 5:27 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: Anand Kapila K April 12, 2019 5:24 PM - SEC Filing UPDATE: Guggenheim Downgrades Eli Lilly (LLY) to Neutral April 11, 2019 6:12 AM - StreetInsider Lilly Confirms Date and Conference Call for First-Quarter 2019 Financial Results Announcement April 10, 2019 4:30 PM - PR NewsWire Form SC 13G Elanco Animal Health Filed by: PRICE T ROWE ASSOCIATES INC /MD/ April 10, 2019 1:54 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 05 Filed by: Shah Aarti S. April 8, 2019 2:55 PM - SEC Filing Form DEF 14A Elanco Animal Health For: May 08 April 3, 2019 4:33 PM - SEC Filing Eli Lilly & Co. (LLY) option implied volatility at low end of 52-week range April 3, 2019 11:06 AM - StreetInsider Form PX14A6G LILLY ELI & CO Filed by: Chevedden John April 2, 2019 10:51 AM - SEC Filing Arteaus Therapeutics Sells Emgality Royalty to Royalty Pharma for $260 Million April 1, 2019 5:00 AM - PR NewsWire Form 4 LILLY ELI & CO For: Mar 26 Filed by: LILLY ENDOWMENT INC March 27, 2019 2:59 PM - SEC Filing Eli Lilly (LLY) PT Raised to $126 at Societe Generale March 27, 2019 1:21 PM - StreetInsider Lilly (LLY) and ImmuNext Announce Licensing and Research Collaboration March 26, 2019 4:30 PM - StreetInsider Lilly and ImmuNext Announce Licensing and Research Collaboration March 26, 2019 4:30 PM - PR NewsWire Form SC 13G Elanco Animal Health Filed by: INTEGRATED CORE STRATEGIES (US) LLC March 25, 2019 5:09 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 22 Filed by: Zakrowski Donald A March 22, 2019 3:17 PM - SEC Filing Form DEFA14A LILLY ELI & CO March 22, 2019 9:11 AM - SEC Filing Form DEFA14A LILLY ELI & CO March 22, 2019 9:07 AM - SEC Filing Form DEF 14A LILLY ELI & CO For: May 06 March 22, 2019 8:59 AM - SEC Filing Eli Lilly (LLY) PT Raised to $121 at Credit Suisse March 22, 2019 3:56 AM - StreetInsider Eli Lilly (LLY) Upside Source Removed After Alzheimer Trial Discontinuation, Reit $134 PT At BMO March 21, 2019 9:28 AM - StreetInsider Form 3 Elanco Animal Health For: Mar 11 Filed by: Scots-Knight Denise March 20, 2019 6:03 PM - SEC Filing Form 3 Elanco Animal Health For: Mar 11 Filed by: McDonald Kirk P March 20, 2019 5:49 PM - SEC Filing Form 3 Elanco Animal Health For: Mar 11 Filed by: Kochevar Deborah Turner March 20, 2019 5:46 PM - SEC Filing Form 3 Elanco Animal Health For: Mar 11 Filed by: BILBREY JOHN P March 20, 2019 5:38 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 18 Filed by: Walker Karen March 20, 2019 2:47 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 18 Filed by: TAI JACKSON P March 20, 2019 2:42 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 18 Filed by: MARRAM ELLEN R March 20, 2019 2:38 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 18 Filed by: LUCIANO JUAN R March 20, 2019 2:18 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 18 Filed by: Alvarez Ralph March 20, 2019 2:11 PM - SEC Filing NCCN Announces Six Quality Improvement Projects in Gastric Cancer Care Approved for Collaboration with Lilly Oncology March 20, 2019 8:45 AM - PR NewsWire Eli Lilly (LLY) PT Raised to $140 at UBS March 20, 2019 7:15 AM - StreetInsider UBS Resumes Eli Lilly (LLY) at Buy March 20, 2019 6:36 AM - StreetInsider Form 8-K LILLY ELI & CO For: Mar 11 March 15, 2019 2:23 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 13 Filed by: HOOVER R DAVID March 14, 2019 6:17 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 12 Filed by: Simmons Jeffrey N March 14, 2019 6:14 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 12 Filed by: Schacht Aaron L March 14, 2019 6:11 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 12 Filed by: Kinard David S March 14, 2019 6:06 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 12 Filed by: LIN SARENA S March 14, 2019 6:04 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 12 Filed by: Cabral Ramiro Martin March 14, 2019 6:01 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 12 Filed by: Urbanek David Alan March 14, 2019 5:57 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 11 Filed by: Urbanek David Alan March 13, 2019 6:12 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 11 Filed by: Simmons Jeffrey N March 13, 2019 6:07 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 11 Filed by: Schacht Aaron L March 13, 2019 6:05 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 11 Filed by: Kinard David S March 13, 2019 6:01 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 11 Filed by: Cabral Ramiro Martin March 13, 2019 5:55 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 11 Filed by: HOOVER R DAVID March 13, 2019 5:52 PM - SEC Filing Eli Lilly & Co. (LLY) call put ratio 2.3 calls to 1 put with focus on March and April 125 puts March 13, 2019 2:49 PM - StreetInsider Active options: GE AAPL BA BAC NVDA LLY ACB ROKU FB March 13, 2019 2:46 PM - StreetInsider Eli Lilly & Co. (LLY) Shares Climb 2% March 13, 2019 2:38 PM - StreetInsider Form 4 LILLY ELI & CO For: Mar 12 Filed by: Fry Stephen F March 13, 2019 12:48 PM - SEC Filing Eli Lilly & Co. (LLY) Briefly Spikes, Pares Gain March 13, 2019 10:18 AM - StreetInsider Form SC TO-I/A LILLY ELI & CO Filed by: LILLY ELI & CO March 13, 2019 9:26 AM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO March 13, 2019 9:16 AM - SEC Filing Lilly (LLY) Reports Final Results of Elanco (ELAN) Exchange Offer March 13, 2019 8:49 AM - StreetInsider Lilly Announces Final Results of Elanco Exchange Offer March 13, 2019 8:48 AM - PR NewsWire Form 8-K Elanco Animal Health For: Mar 11 March 13, 2019 6:48 AM - SEC Filing Elanco Animal Health (ELAN) Appoints Four New Members to Board of Directors March 13, 2019 6:32 AM - StreetInsider Elanco Appoints Four New Members to Board of Directors March 13, 2019 6:30 AM - BizWire Active options: LLY AAPL BA ELAN NVDA GE NIO FB AMD BAC March 12, 2019 9:51 AM - StreetInsider Lilly's (LLY) CYRAMZA Phase 3 RELAY Trial Met Primary Endpoint, Significantly Improving PSFl in First-Line Treatment of Patients with Metastatic EGFR-Mutated NSCLC March 12, 2019 6:46 AM - StreetInsider Lilly's CYRAMZA® (ramucirumab) Phase 3 RELAY Trial Met Primary Endpoint, Significantly Improving Progression-Free Survival in First-Line Treatment of Patients with Metastatic EGFR-Mutated Non-Small C March 12, 2019 6:45 AM - PR NewsWire Active options: LLY AAPL BA ELAN NVDA GE NIO FB AMD BAC TSLA MU March 12, 2019 5:08 AM - StreetInsider JPMorgan Starts Eli Lilly (LLY) at Overweight, Added to Analyst Focus List March 12, 2019 3:06 AM - StreetInsider Form 4 Elanco Animal Health For: Mar 11 Filed by: LILLY ELI & CO March 11, 2019 8:04 AM - SEC Filing Form SC TO-I/A LILLY ELI & CO Filed by: LILLY ELI & CO March 11, 2019 7:37 AM - SEC Filing Form 425 LILLY ELI & CO Filed by: Elanco Animal Health Inc March 11, 2019 7:26 AM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO March 11, 2019 7:16 AM - SEC Filing Elanco Animal Health (ELAN) Completes Separation from Lilly (LLY) March 11, 2019 6:47 AM - StreetInsider Lilly (LLY) Announces Preliminary Results of Elanco (ELAN) Exchange Offer March 11, 2019 6:47 AM - StreetInsider Elanco Animal Health Completes Separation from Lilly March 11, 2019 6:47 AM - BizWire Lilly Announces Preliminary Results of Elanco Exchange Offer March 11, 2019 6:45 AM - PR NewsWire Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO March 8, 2019 5:16 PM - SEC Filing Lilly to Participate in Barclays Global Healthcare Conference March 8, 2019 7:30 AM - PR NewsWire Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO March 7, 2019 5:30 PM - SEC Filing Lilly to Participate in Cowen Health Care Conference March 7, 2019 5:15 PM - PR NewsWire Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO March 7, 2019 9:14 AM - SEC Filing Form SC TO-I/A LILLY ELI & CO Filed by: LILLY ELI & CO March 7, 2019 8:31 AM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO March 7, 2019 8:17 AM - SEC Filing Eli Lilly & Co. (LLY) Announces Final Exchange Ratio of 4.5121 for Elanco (ELAN) Exchange Offer March 7, 2019 6:49 AM - StreetInsider Lilly Announces Final Exchange Ratio of 4.5121 for Elanco Exchange Offer March 7, 2019 6:45 AM - PR NewsWire Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO March 6, 2019 5:10 PM - SEC Filing Active options: LLY GE NIO FB AAPL AMD BAC MU NVDA RIO QCOM March 6, 2019 3:49 PM - StreetInsider Eli Lilly & Co. (LLY) Trades Near Low, Down 1.75% on Heavy Volume March 6, 2019 10:12 AM - StreetInsider Express Scripts (ESRX) is in discussions with Eli Lilly (LLY) about Humalog authorized generic March 6, 2019 9:46 AM - StreetInsider Form 4 Elanco Animal Health For: Mar 01 Filed by: YOUNG TODD S. March 5, 2019 6:18 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 01 Filed by: Urbanek David Alan March 5, 2019 6:11 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 01 Filed by: Simmons Jeffrey N March 5, 2019 6:07 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 01 Filed by: Schacht Aaron L March 5, 2019 6:03 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 01 Filed by: Meer James M March 5, 2019 6:00 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 01 Filed by: LIN SARENA S March 5, 2019 5:57 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 01 Filed by: Kinard David S March 5, 2019 5:54 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 01 Filed by: Hicks Michael-Bryant March 5, 2019 5:42 PM - SEC Filing Form 4 Elanco Animal Health For: Mar 01 Filed by: Cabral Ramiro Martin March 5, 2019 5:36 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO March 5, 2019 5:10 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 01 Filed by: Zakrowski Donald A March 5, 2019 3:52 PM - SEC Filing Form 424B3 Elanco Animal Health March 5, 2019 2:39 PM - SEC Filing Eli Lilly & Co. (LLY) Granted FDA Priority Review Designation for Emgality (galcanezumab-gnlm) Injection for Preventive Treatment of Episodic Cluster Headache in Adults March 5, 2019 6:48 AM - StreetInsider Lilly Receives FDA Priority Review Designation for Emgality® (galcanezumab-gnlm) Injection for the Preventive Treatment of Episodic Cluster Headache in Adults March 5, 2019 6:45 AM - PR NewsWire Form EFFECT Elanco Animal Health March 5, 2019 6:02 AM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO March 4, 2019 5:09 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 01 Filed by: LILLY ENDOWMENT INC March 4, 2019 2:13 PM - SEC Filing BMO Sees Technical Weakness in Eli Lilly (LLY) Shares March 4, 2019 10:36 AM - StreetInsider Eli Lilly & Co. (LLY) Trades at Session Low, Down 2.5% March 4, 2019 10:06 AM - StreetInsider Lilly (LLY) Announces it Will Introduce Lower-Priced Insulin March 4, 2019 6:31 AM - StreetInsider Lilly to Introduce Lower-Priced Insulin March 4, 2019 6:30 AM - PR NewsWire Popular stocks with increasing unusual: LLY ELAN CHK HPQ March 4, 2019 5:23 AM - StreetInsider Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO March 1, 2019 5:47 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 28 Filed by: LILLY ENDOWMENT INC March 1, 2019 1:26 PM - SEC Filing Active options: LLY TSLA BMY JD AMZN SQ AAPL BABA MU AMD March 1, 2019 11:48 AM - StreetInsider Lilly to Present Data Demonstrating Continued Scientific Advancements in Broad Dermatology Portfolio at AAD Annual Meeting March 1, 2019 6:45 AM - PR NewsWire Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 28, 2019 5:04 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 27, 2019 5:04 PM - SEC Filing Popular stocks with increasing unusual: NIO T ELAN KHC JD LLY February 27, 2019 5:54 AM - StreetInsider Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 26, 2019 5:05 PM - SEC Filing Eli Lilly (LLY) PT Raised to $124 at Citi February 26, 2019 5:24 AM - StreetInsider Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 25, 2019 5:06 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 22 Filed by: LILLY ENDOWMENT INC February 25, 2019 4:08 PM - SEC Filing Form PRE 14A LILLY ELI & CO For: May 06 February 25, 2019 6:04 AM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 22, 2019 5:07 PM - SEC Filing Form SC TO-I/A LILLY ELI & CO Filed by: LILLY ELI & CO February 22, 2019 11:56 AM - SEC Filing Form S-4/A Elanco Animal Health February 22, 2019 11:48 AM - SEC Filing Popular stocks with increasing unusual: CVS PCG KO ROKU LLY February 22, 2019 4:29 AM - StreetInsider Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 21, 2019 4:59 PM - SEC Filing Form 8-K LILLY ELI & CO For: Feb 21 February 21, 2019 3:47 PM - SEC Filing Form 424B2 LILLY ELI & CO February 21, 2019 3:14 PM - SEC Filing Form FWP LILLY ELI & CO Filed by: LILLY ELI & CO February 20, 2019 5:13 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 20, 2019 5:09 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 19 Filed by: Alvarez Ralph February 20, 2019 3:57 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 19 Filed by: LUCIANO JUAN R February 20, 2019 3:57 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 19 Filed by: MARRAM ELLEN R February 20, 2019 3:56 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 19 Filed by: TAI JACKSON P February 20, 2019 3:54 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 19 Filed by: Walker Karen February 20, 2019 3:54 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 16 Filed by: Norton Johna February 20, 2019 3:53 PM - SEC Filing Form 4/A LILLY ELI & CO For: Feb 04 Filed by: Zakrowski Donald A February 20, 2019 3:51 PM - SEC Filing Form 4/A LILLY ELI & CO For: Feb 04 Filed by: Shah Aarti S. February 20, 2019 3:48 PM - SEC Filing Form 4/A LILLY ELI & CO For: Feb 04 Filed by: Norton Johna February 20, 2019 3:47 PM - SEC Filing Form 4/A LILLY ELI & CO For: Feb 04 Filed by: Fry Stephen F February 20, 2019 3:46 PM - SEC Filing Form 4/A LILLY ELI & CO For: Feb 04 Filed by: Conterno Enrique A February 20, 2019 3:44 PM - SEC Filing Form 4/A LILLY ELI & CO For: Feb 04 Filed by: Harrington Michael J February 20, 2019 3:43 PM - SEC Filing Form 4/A LILLY ELI & CO For: Feb 04 Filed by: Smiley Joshua L February 20, 2019 3:41 PM - SEC Filing Form 4/A LILLY ELI & CO For: Feb 01 Filed by: O'Neill Myles February 20, 2019 3:40 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 15 Filed by: Conterno Enrique A February 20, 2019 3:38 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 19 Filed by: LILLY ENDOWMENT INC February 20, 2019 1:36 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: Elanco Animal Health Inc February 20, 2019 1:06 PM - SEC Filing Form 10-K Elanco Animal Health For: Dec 31 February 20, 2019 11:10 AM - SEC Filing Form 424B2 LILLY ELI & CO February 20, 2019 8:51 AM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 19, 2019 5:18 PM - SEC Filing Form SC TO-I/A LILLY ELI & CO Filed by: LILLY ELI & CO February 19, 2019 5:15 PM - SEC Filing Form 8-K Elanco Animal Health For: Feb 12 February 19, 2019 5:02 PM - SEC Filing Form S-3ASR LILLY ELI & CO February 19, 2019 2:25 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 19, 2019 11:23 AM - SEC Filing Popular stocks with increasing unusual: LLY EA GRMN SO MAT WIN February 19, 2019 11:15 AM - StreetInsider Form 10-K LILLY ELI & CO For: Dec 31 February 19, 2019 10:44 AM - SEC Filing Pfizer (PFE) and Lilly (LLY) Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain February 19, 2019 6:51 AM - StreetInsider Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain February 19, 2019 6:45 AM - PR NewsWire Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 15, 2019 5:07 PM - SEC Filing Clovis Oncology (CLVS) Takeover Rumblings Continue February 15, 2019 10:10 AM - StreetInsider Lilly Completes Acquisition of Loxo Oncology February 15, 2019 9:23 AM - PR NewsWire Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 14, 2019 4:55 PM - SEC Filing Lilly To Participate in Leerink Partners Global Healthcare Conference February 14, 2019 4:30 PM - PR NewsWire Form SC 13G Elanco Animal Health Filed by: LILLY ELI & CO February 14, 2019 4:26 PM - SEC Filing Eli Lilly & Co. (LLY), Boehringer Ingelheim Report CAROLINA Cardiovascular Outcome Trial of Tradjenta Met Primary Endpoint of Non-Inferiority Compared with Glimepiride February 14, 2019 6:42 AM - StreetInsider Boehringer Ingelheim and Lilly announce the CAROLINA® cardiovascular outcome trial of Tradjenta® met its primary endpoint of non-inferiority compared with glimepiride February 14, 2019 6:30 AM - PR NewsWire Popular stocks with increasing volume: LLY F ATVI FCX February 14, 2019 5:07 AM - StreetInsider Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 13, 2019 5:01 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 12, 2019 5:36 PM - SEC Filing Form SC 13G/A LILLY ELI & CO Filed by: WELLINGTON MANAGEMENT GROUP LLP February 12, 2019 10:00 AM - SEC Filing Increasing unusual call option volume: VOYA ELAN LAD MDCO PTI WMGI RNG KSA WEC VMC OMC LLY SHLDQ BBT February 12, 2019 4:50 AM - StreetInsider Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 11, 2019 5:15 PM - SEC Filing Form 8-K LILLY ELI & CO For: Feb 11 February 11, 2019 5:14 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 11, 2019 5:13 PM - SEC Filing Form SC 13G/A LILLY ELI & CO Filed by: VANGUARD GROUP INC February 11, 2019 11:46 AM - SEC Filing Increasing unusual put option volume: NOG NCR PFF TTM LLY WU EA MSI ICPT MHK SGEN FLR February 11, 2019 5:37 AM - StreetInsider Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 8, 2019 5:35 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 8, 2019 3:28 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 8, 2019 3:19 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 8, 2019 3:18 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: Elanco Animal Health Inc February 8, 2019 3:17 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 8, 2019 3:16 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: Elanco Animal Health Inc February 8, 2019 3:16 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 8, 2019 3:16 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: Elanco Animal Health Inc February 8, 2019 3:15 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 8, 2019 3:14 PM - SEC Filing Form SC TO-I LILLY ELI & CO Filed by: LILLY ELI & CO February 8, 2019 2:52 PM - SEC Filing Form S-4 Elanco Animal Health February 8, 2019 2:06 PM - SEC Filing Lilly to Participate in Guggenheim Healthcare Talks Idea Forum February 8, 2019 1:00 PM - PR NewsWire Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 8, 2019 10:40 AM - SEC Filing Form 8-K Elanco Animal Health For: Feb 08 February 8, 2019 8:23 AM - SEC Filing Form 425 LILLY ELI & CO Filed by: Elanco Animal Health Inc February 8, 2019 8:22 AM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 8, 2019 8:18 AM - SEC Filing Elanco Animal Health to File Registration Statement in Connection With Lilly Divestiture Announcement February 8, 2019 7:45 AM - BizWire Lilly (LLY) to Initiate Divestiture of its Remaining Interest in Elanco Animal Health (ELAN) February 8, 2019 6:46 AM - StreetInsider Lilly Will Initiate Divestiture of its Remaining Interest in Elanco Animal Health February 8, 2019 6:45 AM - PR NewsWire Form 425 LILLY ELI & CO Filed by: Elanco Animal Health Inc February 7, 2019 5:24 PM - SEC Filing Eli Lilly (LLY) PT Raised to $115 at Credit Suisse February 7, 2019 7:59 AM - StreetInsider Eli Lilly (LLY) PT Raised to $134 at BMO Capital February 7, 2019 7:44 AM - StreetInsider Form 4 LILLY ELI & CO For: Feb 04 Filed by: Zakrowski Donald A February 6, 2019 8:31 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 01 Filed by: O'Neill Myles February 6, 2019 8:12 PM - SEC Filing Form 3/A LILLY ELI & CO For: Jan 01 Filed by: O'Neill Myles February 6, 2019 8:07 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: Smiley Joshua L February 6, 2019 8:04 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: Zulueta Alfonso G February 6, 2019 7:59 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: White Anne E. February 6, 2019 7:54 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: Skovronsky Daniel February 6, 2019 7:40 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: Shah Aarti S. February 6, 2019 7:37 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: Ricks David A February 6, 2019 7:30 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: Norton Johna February 6, 2019 7:23 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: Harrington Michael J February 6, 2019 7:17 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: Fry Stephen F February 6, 2019 7:11 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: Conterno Enrique A February 6, 2019 7:03 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 04 Filed by: Barnes Melissa S February 6, 2019 7:01 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 6, 2019 5:46 PM - SEC Filing Form 425 LILLY ELI & CO Filed by: LILLY ELI & CO February 6, 2019 5:45 PM - SEC Filing Eli Lilly (LLY) PT Raised to $143 at Cantor Fitzgerald February 6, 2019 1:28 PM - StreetInsider Form 8-K LILLY ELI & CO For: Feb 06 February 6, 2019 9:49 AM - SEC Filing Form 8-K Elanco Animal Health For: Feb 06 February 6, 2019 6:53 AM - SEC Filing Eli Lilly & Co. (LLY) Misses Q4 EPS by 1c, Revenue Beats, FY19 EPS Guidance Misses February 6, 2019 6:27 AM - StreetInsider Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology February 6, 2019 6:25 AM - PR NewsWire Elanco Animal Health Reports Strong 2018 Fourth Quarter and Full Year Results, Confirms 2019 Guidance February 6, 2019 6:25 AM - BizWire Popular stocks with increasing volume: SBUX GM SNAP CRON LLY EA ADM SWKS February 6, 2019 5:32 AM - StreetInsider Form 4 LILLY ELI & CO For: Feb 01 Filed by: Zulueta Alfonso G February 5, 2019 7:10 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 01 Filed by: Ricks David A February 5, 2019 7:05 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 01 Filed by: Harrington Michael J February 5, 2019 7:00 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 01 Filed by: Fry Stephen F February 5, 2019 6:56 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 01 Filed by: Conterno Enrique A February 5, 2019 6:50 PM - SEC Filing Form 4 LILLY ELI & CO For: Feb 01 Filed by: Barnes Melissa S February 5, 2019 6:44 PM - SEC Filing Form SC 13G/A LILLY ELI & CO Filed by: BlackRock Inc. February 4, 2019 4:55 PM - SEC Filing Form 4 LILLY ELI & CO For: Jan 31 Filed by: Zulueta Alfonso G February 4, 2019 4:33 PM - SEC Filing Eli Lilly & Co. (LLY), Incyte Corporation (INCY) Report Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis February 4, 2019 6:46 AM - StreetInsider Lilly Announces Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis February 4, 2019 6:45 AM - PR NewsWire Senator Sanders asks why drug, once free, now costs $375k February 4, 2019 6:04 AM - StreetInsider Eli Lilly & Co. (LLY) option implied volatility flat into President Trump State of Union Address February 4, 2019 6:02 AM - StreetInsider Form 4/A LILLY ELI & CO For: Jul 26 Filed by: TAI JACKSON P February 1, 2019 3:03 PM - SEC Filing Form 4/A LILLY ELI & CO For: Dec 10 Filed by: O'Neill Myles February 1, 2019 2:55 PM - SEC Filing Form 4/A LILLY ELI & CO For: Apr 13 Filed by: Mahony Susan February 1, 2019 2:39 PM - SEC Filing Form 5 LILLY ELI & CO For: Dec 31 Filed by: Simmons Jeffrey N February 1, 2019 2:09 PM - SEC Filing Form 5 LILLY ELI & CO For: Dec 31 Filed by: Zakrowski Donald A February 1, 2019 2:05 PM - SEC Filing Form 5 LILLY ELI & CO For: Dec 31 Filed by: Shah Aarti S. February 1, 2019 2:02 PM - SEC Filing Form 5 LILLY ELI & CO For: Dec 31 Filed by: Harrington Michael J February 1, 2019 1:59 PM - SEC Filing Form 5 LILLY ELI & CO For: Dec 31 Filed by: Barnes Melissa S February 1, 2019 1:55 PM - SEC Filing Lilly (LLY) and Loxo Oncology (LOXO) Announce Expiration of HSR Act Waiting Period for Proposed Transaction February 1, 2019 6:49 AM - StreetInsider Lilly and Loxo Oncology Announce Expiration of HSR Act Waiting Period in Connection with Proposed Transaction February 1, 2019 6:45 AM - Globe NewsWire Lilly and Loxo Oncology Announce Expiration of HSR Act Waiting Period in Connection with Proposed Transaction February 1, 2019 6:45 AM - PR NewsWire Lilly (LLY) Announces FDA Expanded its ALIMTA Label with Combination of KEYTRUDA and Platinum Chemotherapy for First-Line Treatment of Metastatic Nonsquamous NSCLC January 31, 2019 6:51 AM - StreetInsider FDA Expands Lilly's ALIMTA® (pemetrexed) Label with Combination of KEYTRUDA® (pembrolizumab) and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Canc January 31, 2019 6:45 AM - PR NewsWire Lilly (LLY) will announce results on Wednesday, February 6, one week earlier than previously scheduled January 30, 2019 3:16 PM - StreetInsider Lilly Revises Date for Fourth-Quarter 2018 Financial Results Announcement January 30, 2019 3:15 PM - PR NewsWire Elanco Revises Date for Fourth Quarter 2018 Financial Results January 30, 2019 3:15 PM - BizWire Pfizer (PFE), Lilly (LLY) Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain January 29, 2019 6:34 AM - StreetInsider Pfizer and Lilly Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain January 29, 2019 6:30 AM - BizWire Elanco Animal Health and Performance Livestock Analytics Establish Data Service Agreement January 28, 2019 7:00 AM - BizWire 111, Inc. to Collaborate with Lilly in Creating New Solutions for Pharmaceutical Distribution January 28, 2019 6:23 AM - StreetInsider CVS Health (CVS) to Cover Migraine Drugs from Teva Pharma (TEVA), Eli Lilly & Co. (LLY), Excludes Amgen (AMGN) - Reuters January 25, 2019 2:30 PM - StreetInsider Form 4 LILLY ELI & CO For: Jan 22 Filed by: Walker Karen January 24, 2019 8:42 PM - SEC Filing Form 4 LILLY ELI & CO For: Jan 22 Filed by: TAI JACKSON P January 24, 2019 6:26 PM - SEC Filing Form 4 LILLY ELI & CO For: Jan 22 Filed by: MARRAM ELLEN R January 24, 2019 6:20 PM - SEC Filing Form 4 LILLY ELI & CO For: Jan 22 Filed by: LUCIANO JUAN R January 24, 2019 6:14 PM - SEC Filing Form 4 LILLY ELI & CO For: Jan 22 Filed by: Alvarez Ralph January 24, 2019 6:08 PM - SEC Filing FDA Recommends New Patients Not to Start Using Lilly's (LLY) Lartruvo, Also Directs Patients on it to Talk to Doctor - Bloomberg, Citing email January 24, 2019 2:50 PM - StreetInsider Government Employees Affected by Federal Shutdown Encouraged to Contact Lilly Diabetes Solution Center to Access Insulin January 23, 2019 8:00 AM - PR NewsWire UBS Starts Eli Lilly (LLY) at Buy January 23, 2019 5:21 AM - StreetInsider Lilly Confirms Date and Conference Call for Fourth-Quarter 2018 Financial Results Announcement January 21, 2019 6:09 PM - PR NewsWire Full Article List